Roger Frigério Castilho

Dr. Roger Frigério Castilho

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
AKAlicia J. Kowaltowski
Alicia J. Kowaltowski
NSNadja Cristhina de Souza-Pinto
Nadja Cristhina de Souza-Pinto
RCRoger Frigério Castilho
Roger Frigério Castilho
AVAnibal E. Vercesi
Anibal E. Vercesi

19 April 2001 in FEBS Letters
Verified
Journal Article
Closed access
AKAlicia J. Kowaltowski
Alicia J. Kowaltowski
RCRoger Frigério Castilho
Roger Frigério Castilho
AVAnibal E. Vercesi
Anibal E. Vercesi

13 July 2003 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
GMGustav Mattiasson
Gustav Mattiasson
MSMehrdad Shamloo
Mehrdad Shamloo
GGGunilla Gido
Gunilla Gido
KMKavitha Mathi
Kavitha Mathi
GTGregor Tomasevic
Gregor Tomasevic
TWTadeusz Wieloch
Tadeusz Wieloch

1 June 2013 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
TFTiago R. Figueira
Tiago R. Figueira
MBMario Barros
Mario Barros
ACAnamaria Camargo
Anamaria Camargo
RCRoger Frigério Castilho
Roger Frigério Castilho
Julio Cesar Batista FerreiraJulio Cesar Batista Ferreira
Julio Cesar Batista Ferreira
AVAnibal Eugenio Vercesi
Anibal Eugenio Vercesi
Mitochondrially generated reactive oxygen species are involved in a myriad of signaling and damaging pathways in different tissues. In addition, mitochondria are an important target of reactive oxygen and nitrogen species. Here, we discuss basic mechanisms of mitochondrial oxidant generation and removal and the main factors affecting mitochondrial redox balance. We also discuss the interaction between mitochondrial reactive oxygen and nitrogen species, and the involvement of these oxidants in mitochondrial diseases, cancer, neurological, and cardiovascular disorders. Antioxid. Redox Signal. 18, 2029–2074.

1 October 2013 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JRJuliana A. Ronchi
Juliana A. Ronchi
TFTiago R. Figueira
Tiago R. Figueira
FRFelipe G. Ravagnani
Felipe G. Ravagnani
HOHelena C. F. Oliveira
Helena C. F. Oliveira
AVAnibal E. Vercesi
Anibal E. Vercesi
RCRoger Frigério Castilho
Roger Frigério Castilho

1 March 2000 in Cell Transplantation
Verified
Journal Article
Open access
PDF file
PBPatrik Brundin
Patrik Brundin
JKJenny Karlsson
Jenny Karlsson
MEMia Emgård
Mia Emgård
GSGabriele S. Kaminski Schierle
Gabriele S. Kaminski Schierle
OHOskar Hansson
Oskar Hansson
RCRoger Frigério Castilho
Roger Frigério Castilho
Neural transplantation is developing into a therapeutic alternative in Parkinson's disease. A major limiting factor is that only 3–20% of grafted dopamine neurons survive the procedure. Recent advances regarding how and when the neurons die indicate that events preceding actual tissue implantation and during the first week thereafter are crucial, and that apoptosis plays a pivotal role. Triggers that may initiate neuronal death in grafts include donor tissue hypoxia and hypoglycemia, mechanical trauma, free radicals, growth factor deprivation, and excessive extracellular concentrations of excitatory amino acids in the host brain. Four distinct phases during grafting that can involve cell death have been identified: retrieval of the embryo; dissection and preparation of the donor tissue; implantation procedure followed by the immediate period after graft injection; and later stages of graft maturation. During these phases, cell death processes involving free radicals and caspase activation (leading to apoptosis) may be triggered, possibly involving an increase in intracellular calcium. We review different approaches that reduce cell death and increase survival of grafted neurons, typically by a factor of 2–4. For example, changes in transplantation procedure such as improved media and implantation technique can be beneficial. Calcium channel antagonists such as nimodipine and flunarizine improve nigral graft survival. Agents that counteract oxidative stress and its consequences, such as superoxide dismutase overexpression, and lazaroids can significantly increase the survival of transplanted dopamine neurons. Also, the inhibition of apoptosis by a caspase inhibitor has marked positive effects. Finally, basic fibroblast growth factor and members of the transforming growth factor-beta superfamily, such as glial cell line-derived neurotrophic factor, significantly improve the outcome of nigral transplants. These recent advances provide hope for improved survival of transplanted neurons in patients with Parkinson's disease, reducing the need for human embryonic donor tissue and increasing the likelihood of a successful outcome.